Trulieve Cannabis Corp.
TRUL
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.07% | 2.77% | 0.21% | -4.30% | -7.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.07% | 2.77% | 0.21% | -4.30% | -7.31% |
| Cost of Revenue | -12.92% | -10.59% | -5.74% | -0.58% | 2.35% |
| Gross Profit | 21.60% | 15.12% | 5.42% | -7.30% | -14.70% |
| SG&A Expenses | 32.19% | 6.31% | -7.64% | -9.06% | -8.55% |
| Depreciation & Amortization | 2.71% | -0.91% | -4.27% | -8.67% | -5.63% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.54% | -2.99% | -6.33% | -4.82% | -2.83% |
| Operating Income | -0.17% | 109.70% | 92.04% | 0.56% | -38.83% |
| Income Before Tax | 115.01% | 120.72% | 124.66% | -640.93% | -1,373.22% |
| Income Tax Expenses | 30.54% | 28.12% | 28.02% | 10.05% | -7.35% |
| Earnings from Continuing Operations | 64.47% | 71.74% | 81.74% | -123.81% | -138.61% |
| Earnings from Discontinued Operations | 94.06% | 97.50% | 97.30% | 28.20% | -42.55% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.31% | -3.31% | -27.05% | 32.65% | 28.87% |
| Net Income | 70.56% | 77.43% | 85.76% | -74.60% | -114.09% |
| EBIT | -0.17% | 109.70% | 92.04% | 0.56% | -38.83% |
| EBITDA | -1.69% | 24.52% | 23.43% | -3.27% | -19.17% |
| EPS Basic | 70.71% | 77.52% | 85.78% | -74.17% | -113.30% |
| Normalized Basic EPS | 43.57% | 1,142.04% | 597.67% | 11.50% | -64.20% |
| EPS Diluted | 70.71% | 77.52% | 85.78% | -74.17% | -113.30% |
| Normalized Diluted EPS | 43.57% | 1,142.04% | 597.67% | 11.50% | -64.20% |
| Average Basic Shares Outstanding | 0.54% | 0.44% | 0.32% | 0.40% | 0.56% |
| Average Diluted Shares Outstanding | 0.54% | 0.44% | 0.32% | 0.40% | 0.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
